HopeStage
Back to all studies
CompletedNCT01355952

Alpha-Lipoic Acid Studied for Weight Management in Schizophrenia

About this titleRead the official source — NCT01355952
Interventional studyAges 18–70United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2011
Recruitment status
Completed
Enrollment listed in the registry
17
Sponsor
Yale University
Sponsor type
University
Study type
Other
Intervention type
DIETARY_SUPPLEMENT
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT01355952
Official title
Show the full official title

An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies